Rosetta Stone Financials

Rosetta Stone Stock Summary

Rosetta Stone competes with Flex, Amgen, Talis Biomedical, Amkor Technology, and Blue Hat. Rosetta Stone Inc., together with its subsidiaries, provides technology-based learning products in the United States and internationally. Rosetta Stone Inc. was founded in 1992 and is headquartered in Arlington, Virginia. Rosetta Stone operates under SoftwareApplication classification in the United States and is traded on New York Stock Exchange. It employs 746 people.

Rosetta Stone Key Financial Ratios

Generally speaking, Rosetta Stone's financial ratios allow both analysts and investors to convert raw data from Rosetta Stone's financial statements into concise, actionable information that can be used to evaluate the performance of Rosetta Stone over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Rosetta Stone reports annually and quarterly.

Rosetta Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Rosetta Stone's current stock value. Our valuation model uses many indicators to compare Rosetta Stone value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Rosetta Stone competition to find correlations between indicators driving Rosetta Stone's intrinsic value. More Info.Rosetta Stone is currently regarded as top stock in return on equity category among related companies. It is currently regarded as top stock in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Rosetta Stone by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Rosetta Stone's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Rosetta Stone's earnings, one of the primary drivers of an investment's value.

Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

If you are still planning to invest in Rosetta Stone check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Rosetta Stone's history and understand the potential risks before investing.